Models

Submission ID Name Format Submitter Submitted Sort Ascending Modified Certification
DDMODEL00000244 Non-linear saturable pharmacokinetic model for high dose rifampicin in tuberculosis patients Original code Robin Svensson 2017/08/11 2017/08/11 uncertified model
DDMODEL00000243 Time to event modelling of competing risks Original code Joachim Grevel 2017/07/12 2017/07/19 uncertified model
DDMODEL00000240 The Multistate Tuberculosis Pharmacometric model Original code Oskar Clewe 2017/05/10 2017/05/10 uncertified model
DDMODEL00000239 Daily and aggregated seizure counts model for scaling from adults to children in epilepsy Original code Rik Schoemaker 2017/05/03 2017/05/15 uncertified model
DDMODEL00000238 Population PK model for gentamicin Original code Eva Germovsek 2017/03/28 2017/03/28 uncertified model
DDMODEL00000237 Zurlinden_2016_Population_PBPK_model_for_acetaminophen Original code Nan-Hung Hsieh 2017/03/27 2017/03/29 uncertified model
DDMODEL00000233 Zierhut_2008_Population PKPD model for Fc-osteoprotegerin in healthy postmenopausal women PharmML 0.8.x Kyle Baron 2016/11/18 2018/07/13 uncertified model
DDMODEL00000231 PK/PD model of sunitinib in non-small cell lung cancer patients PharmML Moran Optimata 2016/10/27 2016/10/27 uncertified model
DDMODEL00000230 A pharmacokinetic model for interleukin-21 therapy validated prospectively in murine experiments in melanoma PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
Showing 41 to 50 of 151 models
First Previous 5 6 7 8 9 Next Last
 
Help